Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.

Lee N, Woodrum CL, Nobil AM, Rauktys AE, Messina MP, Dabora SL.

BMC Pharmacol. 2009 Apr 15;9:8. doi: 10.1186/1471-2210-9-8.

PMID:
19368729
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model.

Rauktys A, Lee N, Lee L, Dabora SL.

BMC Dermatol. 2008 Jan 28;8:1. doi: 10.1186/1471-5945-8-1.

PMID:
18226258
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk